Invest in Interbio International Inc.

InterBio International Inc (“III”) is incorporated in the [State of Wyoming in US] as the issuer and directly owns 70% of InterBio Solutions Pte Ltd (“IBS”), a Singapore incorporated company providing an integrated management solution for treating poultry, plant and food wastes making it ecologically safe and economical for reuse as matured compost (as organic mineral fertilizer).

Raising
USD$ 3 Million

Three million InterBio International Inc (“III”) shares to be placed out at US$1 per share, minimum lot of US$500 each.

Durability and environmental friendliness are gaining more and more popularity amongst consumers in various sectors.

There are multiple economical and environmental advantages of our organic mineral fertilizers generated by our unique and patented waste to fertilizers integrated system. These fertilizers are completely built from natural raw materials of plant or animal origin which help improve the soil’s health and condition, and thus increasing harvest yields. 

What problems are IBS addressing :

  • SET service – procurement, installation and management of W2OMF SET – estimated to be US$1m – US$7m depending on the capacity of the facility.
  • Share of profit from JV (arising from the sales of organic mineral fertilizer)
  • W2OMF management fee – 2% per year of US$1m to US$8m per set
  • Licensed by W2OMF Master Licensor – Sistema InterBio Pte Ltd, being the master licensor licenses the intellectual property right to IBS, the sole and exclusive sub-licensee, for use of the W2OMF system, know-how and technology to provide SET service.
  • Joint Venture Structure with waste generators – IBS set up a Joint Venture (“JV”) with the waste generator (“Local Sponsor(s)”), the shareholdings of which between two parties will be based on their profit-sharing agreement on the sales of fertilizers, the converted waste (which in turn depends on what stage the Sponsor is at i.e. are they just waste generators or are they waste collectors – do they have any on-going treatment facilities etc.). The JV is located at the waste generating area of the Sponsor to receive waste for fertilizer treatment and generation.
  • Service fee charged for the provision of SET – IBS will utilize its right to use the W2OMF technology to provide “SET” service (service & support, equipment, technology) to the JV of the first four projects which includes installation of the necessary physical structure, facilities, and software system (“Operating Asset”). The JV will own the Operating Asset of SET. The service fee for each SET depends on the funds raised by IBS but it shall be at least 20% of the cost of the SET that the supplier ORGANOVITA S.R.L. quotes to the JV.
  • Profit sharing from the sales of organic mineral fertilizer by JV –  The JV runs the W2OMF business where the sales of fertilizer and the cost of running the W2OMF are absorbed by the The profit of the JV from the sales less direct and operating costs, shall be shared between the JV partners by dividend (IBS and Sponsor) according to their shareholding in the JV.
  • As the Italian W2OMF supplier of the SET, they will continue toprovide on-going service support, equipment and technology to the Asset Co (which is the legal owner of the Operating Assets).

Our target is a niche market because there are no organic-mineral fertilizer plants produced from the same source input materials that IBS will use.

This segment covers food, animal and plant waste and existing known technologies and processes take at least twice or longer to process such waste into compost (not fertilizers) of any value.​

In terms of treatment – Our technology, systems and processes is an integrated system which is economically sustainable being low in capex and opex and environmentally compliant since at every stage of the process, it emits the lowest level of CO2 and Greenhouse gasses.

The treatment lines are modular, so they are scalable according to the volume increase for existing treatment plants. All major plantations, mill owners and operators, poultry farm companies or chicken co-operatives, need a treatment plant in order to comply with agriculture and environmental regulations. A very high percentage have either no treatment facility in place or have facilities which are not yet ESG compliant.

We have no production constraints in terms of capabilities and conservatively project to have 2-3 new plants in Europe alone of up 50,000 tonnes output. There are also needs within the treatment part of the waste now still unresolved with existing processing facilities using other technologies which are now seeking IBS’s assistance.

For the plantations segment, because the target buyers are themselves the waste generators which we will be servicing, the treated waste-to-fertilizer will be customized for their plant type, reducing their need to import and use chemical fertilizers which results in cost-saving and the remediation of the soil and improvement of the crop yields in their plantation.

Purchases are made for both matured compost and organic mineral fertilizers, used for pre-sowing and thereafter leading up to harvesting season. Frequency of purchase depends on the plant type and the harvesting cycle. These are all captured and high-repeat customers once they start to use or buy the matured compost and/ or organic mineral fertilizers for themselves or their end-user farmers in the case of co-operatives.

According to Data Bridge’s market research, the organic-mineral fertilizer market is expected to increase in the forecast period from 2020-2027 with a CAGR of 4.7% and is expected to reach USD616.33 million by 2027.

Our market growth is made conservatively in line with our customers’ needs ranging from end-user customers to organic fertilizer importers/wholesalers which are in line with the research data above.

Based on the type of crop, the organic-mineral fertilizer market is segmented into fruits and nuts, vegetables, flowers, tea plants, field crops (like corn, wheat etc.), turf and ornamental and others. In 2020, the field crop segment dominated the organic-mineral fertilizer market as it helps to improve soil fertility, thereby improving the nutrient content of the field crops. This in turn increases the growth of the organic fertilizer and minerals market.

Our target growth is 2-3 treatment facilities per year for Year 1 and 2-5 treatment facilities from Year 2.

III Financial Targets

Management Team

Mr Chng Hee Kok - Non Executive Chairman

  • Mr Chng was formerly a Member of Parliament of Singapore from 1984 to 2001. His business experience and leadership positions spanned across Manufacturing, Property Development, Hotel Management, Trading, Entertainment and Food & Beverage Industries. He was the Chief Executive Officer of Yeo Hiap Seng Ltd, Scotts Holdings Limited, Hartawan Holdings Limited, HG Metals Manufacturing Limited and LH Group Limited.
  • He held past directorships at Public Utilities Board, Sentosa Development Corporation and Singapore Institute of Directors.
  • Mr Chng currently serves as an Independent Director in Metech International Limited, in Full Apex (Holdings) Limited, Luxking Group Holdings Limited, United Food Holdings Limited, The Place Holdings Ltd., Blackgold Natural Resources Limited, Sandpiper Digital Payment AG and as Chairman and Independent Director in Ellipsiz Ltd.
  • Mr Chng graduated from the University of Singapore with a First Class Honours degree in Mechanical Engineering and was awarded Institute of Engineers Singapore Gold Medal and Mobil Silver Medal. He also holds a Master of Business Administration degree from the National University of Singapore, and completed the Program for Executive Development at Lausanne Switzerland.

Edmund Heng - Chief Executive Director

  • More than 3 years’ experiences in building strong links between business strategy, financial and operational planning, ability to link financial targets to operational drivers and other day-to-day activities, maintaining stakeholders, shareholders and investors relationship, adhering to Regulatory affairs, auditors’ relationship, other statutory boards;
  • Graduated at Royal Roads University, Canada in International Master of Business Administration in Executive Management;
  • Executive Director / Chief Executive Director at JASPER INVESTMENT LIMITED, a Main Board Listed Company on Singapore Stock Exchange, taking overall responsibility for creating, planning, implementing and integrating the strategic direction and resources of the Company (2018 to 2020);
  • Independent Director at JASPER INVESTMENT LIMITED to oversees Regulatory Affairs pertaining to Stock Exchange of Singapore Listing Regulation requirement (2018);
  • Business Adviser at SOLCOFIN PTE LTD (2014 to 2017);
  • Personal Adviser to the President Director at EVERGREEN MARINE & EVA AIR (2000 to 2013).

Lothar Deyerling - Chief Operating Officer

  • More than 3 years’ experiences in building strong links between business strategy, financial and operational planning, ability to link financial targets to operational drivers and other day-to-day activities, maintaining stakeholders, shareholders and investors relationship, adhering to Regulatory affairs, auditors’ relationship, other statutory boards;
  • Graduated at Royal Roads University, Canada in International Master of Business Administration in Executive Management;
  • Executive Director / Chief Executive Director at JASPER INVESTMENT LIMITED, a Main Board Listed Company on Singapore Stock Exchange, taking overall responsibility for creating, planning, implementing and integrating the strategic direction and resources of the Company (2018 to 2020);
  • Independent Director at JASPER INVESTMENT LIMITED to oversees Regulatory Affairs pertaining to Stock Exchange of Singapore Listing Regulation requirement (2018);
  • Business Adviser at SOLCOFIN PTE LTD (2014 to 2017);
  • Personal Adviser to the President Director at EVERGREEN MARINE & EVA AIR (2000 to 2013).

Alberto Rocca - Commercial Director

  • Graduated in Accounting c/o Istituto Statale LUIGI EINAUDI of Bassano del Grappa (VI) – Italy
  • Managing Director at ASF Algerian Seals Factory, (2019 to date);
  • Global Sales and Marketing Manager at Carrara Group – Adro (BS) working in the Sealing Technologies (Total Turnover EUR50 Million), with the focus on NBD and task in developing a growth plan (including a Merger & Acquisitions program) (2017 to date);
  • Global Channel Leader at W.L. Gore & Associates, Performance Solution Division taking the Responsibility of Global Distribution Network, Agents, Service Providers, Value Added Resellers (2016 to 2017);
  • Sealant Technologies Group European Business Leader (including Russia, Middle East and Africa) at W.L. Gore & Associates, taking the Responsibility of the whole EU Team (50 Associates), Profit & Loss and coordination of R&D activities in EU (2007 to 2016);

Frequently Ask Questions

Interbio is a Singapore incorporated company providing an integrated management solution for treating poultry, plant and food wastes making it ecologically safe and economical for reuse as matured compost (as organic mineral fertilizer).

There are multiple economical and environmental advantages of Interbio’s organic mineral fertilizers generated by their unique and patented waste to fertilizers integrated system. These fertilizers are completely built from natural raw materials of plant or animal origin which help improve the soil’s health and condition, and thus increase harvest yields. Interbio’s solution also minimize waste generators’ use of untreated landfills, eliminates the impact of waste on the environment and meets government’s stringent compliance and regulations’ requirements.

Interbio aims to eliminate the impact of wastes on the environment, comply with government regulations on the cessation of use of untreated landfills and in some cases, eliminate NIMBY “not in my back yard” protests, eliminate high capital and operating costs in the storage, recovery and disposal of waste, and eliminate farmers’ use of chemical fertilizers, pesticides thus continuing soil toxicity and contamination of underground water resulting in lower crop yield.

IBS Revenue Streams :

(1) SET service – procurement, installation and management of W2OMF SET – estimated to be US$3m – US$9.5m depending on the
capacity of the facility.

(2) Share of profit from JV (arising from the sales of organic
mineral fertilizer).

(3) W2OMF management fee – 2% per year of US$3m to US$9m per
set.

(1) ORGANOVITA S.R.L. – the developer of the system and know-how of the waste-to-organic mineral fertilizer “W2OMF” (developed and owned by the Italian W2OMF investor). 

(2) SISTEMA INTERBIO PTE LTD – owns the right to use the intellectual property of W2OMF and will license the right to use the W2OMF to IBS for its Asian and European Projects.

COMPOTRADE S.R. L., ORGANOVITA S.R.I., FARMERS CO-OPERATIVES,
STATE-OWNED ORGANIC FERTILIZER ENTERPRISES.

Interbio’s target is a niche market because there are no organic-mineral fertilizer plants produced from the same source input materials that IBS will use. This segment covers food, animal and plant waste and existing known technologies and processes take at least twice or longer to process such waste into compost (not fertilizers) of any value.

According to Data Bridge’s market research, the organic-mineral fertilizer market is expected to increase in the forecast period from 2020-2027 with a CAGR of 4.7% and is expected to reach USD 616.33 million by 2027. Interbio’s market growth is made conservatively in line with their customers’ needs ranging from end-user customers to organic fertilizer importers/wholesalers which are in line with the research data above. Based on the type of crop, the organic-mineral fertilizer market is segmented into fruits and nuts, vegetables, flowers, tea plants, field crops (like corn, wheat etc.), turf and ornamental and others. In 2020, the field crop segment dominated the organic-mineral fertilizer market as it helps to improve soil fertility, thereby improving the nutrient content of the field crops. This in turn increases the growth of the organic fertilizer and minerals market. Interbio’s target growth is 2-3 treatment facilities per year for Year 1 and 2-5 treatment facilities from Year 2.

Interbio’s unfair advantages are first mover, connections, support base, captive customers, technology advantage, brand advantage for the organic-mineral fertilizers, system advantage in terms of cost and treatment time saving, sustainable, low capex and opex; fertilizer pricing well-within market tolerance; several revenue streams apart from sales of fertilizers (e.g. carbon credits).

Interbio’s growth and expansion plan is to strengthen their technology and big data analytics capabilities, expand their sales force in Asia and around the world, expand their customer base by implementing various branding initiatives and targeted marketing as well as expanding the depth of their customer-centric services through proprietary, enhance their profitability by expanding and optimizing the service mix, enhance their core competencies in risk management, internal control and asset management to further drive operating efficiency.

US $500 for 500 shares; $1 per share

There are no plan to release dividends at this time.

Interbio is offering 3 million shares placed out at $1 a share.

Funds raised will be used to fund JV for the purchase of Operating Assets for W2OMF business and expand IBS service coverage and market presence. It will also help expansion to regions within Italy and Romania and potentially to other East European countries – Uzbekistan, Kazakhstan and expansion to SE Asia (Philippines , Indonesia, Malaysia , Thailand , Cambodia).

Interbio will provide corporate updates every quarter.

The theoretical share price by DCF valuation is $3.1 which has a share up times of 3.1 from the offering price of $1.

Interbio is confident that this placement will be fully subscribed and  will operate the business as planned even with a lower subscription rate for this placement of shares.

  • 80% Founders (40% Allievi S.r.l – the Italian inventor who owns the IP and 40% Yuan Wei Holdings Pte Ltd.)
  • 10% Directors and Advisor (5% Chng Hee Kok and 5% Apex Capital Pte Ltd).
  • 10% to be reserved for public Investors (inclusive of this round and future fundraising)

Interbio plans to IPO sometime in the future but has no set time frame as of now.

Each SET is sold to an Asset Co for a sum which is equivalent to the project cost. As an illustration, where the project cost is US$9m, IBS makes a gross margin of $3m, Sponsor to invest $3m and IBS bring in investors/funds to take up $3m.

Interbio’s operating expenses include director fee & staff cost, bank charges, rental expenses, office expenses, marketing & business development, government fee, accounting & audit fee, professional fee, and listing compliance fee. The operating profit margin percentage is projected to be 80% for year 1 and 95% onwards.

Interbio is utilizes a sustainable asset-light strategy with low Capex and Opex.

Contact Us

Ms Kay Swee Tuan
Ph: +65 9816 8911
tuankay@gmail.com

Scroll to Top